Navigation Links
Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:6/5/2010

CHICAGO, June 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of six studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of biological similarities and differences between stage II and III colon cancer, suggesting a potential role for the Oncotype DX® colon cancer test in patients with stage III disease, pending further study. The company also announced the first presentation of results from its collaboration with Pfizer Oncology for assessing prognosis for early-stage renal cell carcinoma.

"With our innovative clinical collaborations and access to numerous landmark trials, we have the opportunity to advance the quality of cancer treatment decisions as evidenced by the six studies being presented at ASCO," said Steven Shak, M.D., chief medical officer of Genomic Health.  "Collectively these results reflect our efforts to continue adding value to the Oncotype DX breast and colon cancer tests, while advancing our broad and deep product pipeline aimed at optimizing treatment decisions in multiple tumor types."

Potential Role for Oncotype DX Colon Cancer Test in Stage III Disease

An evaluation of biological similarities and differences between stage II and III colon cancer suggests that the Oncotype DX colon cancer Recurrence Score®, currently available for treatment planning in stage II colon cancer, may also predict recurrence risk in stage III colon cancer. The study, "Comparison of molecular and pathologic features of stage II and stage III colon cancer in 4 large studies conducted for development of
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
2. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
3. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
4. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
5. Trinean Reduces Volume and Time Requirements for Genomic DNA Quantification
6. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
7. Genedata Announces Five-Year Agreement Extension with Kluyver Centre for Genomics of Industrial Fermentation
8. The Protein Structure Initiative announces free OpenHelix tutorial and training materials for the Structural Genomics Knowledgebase (SGKB)
9. Institute for Systems Biology uses Complete Genomics genome sequencing service to verify gene responsible for Miller syndrome
10. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
11. Melanoma transcriptome reveals novel genomic alterations not seen before
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
(Date:12/22/2014)... Md. , Dec. 22, 2014 /PRNewswire/ ... SYN), a developer of pathogen-specific therapies for ... on protecting the microbiome, today announced positive ... Phase 1a clinical trial of SYN-004, the ... prevention of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... Dec. 22, 2014  Alternative Energy & Environmental ... has signed a letter of intent to acquire ... and patented a nanotechnology-based development platform used to ... enable rapid on-site collection and testing to identify ... issues in an immediate, non-invasive and cost-effective manner. ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2
... 8, 2011 Golden Seeds, an investment firm dedicated ... empowerment of women entrepreneurs, announced today that it has ... in Pittsburgh, Pennsylvania to support the growing number of ... state-wide in Pennsylvania.  Since its first Pittsburgh investment in ...
... 8, 2011 Reportlinker.com announces that a new ... catalogue: Global High Throughput ... http://www.reportlinker.com/p0611062/Global-High-Throughput-Screening-HTS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc This report analyzes ... (HTS) in US$ Million. The report provides ...
... September 7, 2011 Scientists at The Scripps Research Institute ... hydrocephalus, one of the most common neurological disorders of childhood ... newborn children. The research appears in the September 7, ... Hydrocephalus, which involves excess buildup of cerebrospinal fluid in ...
Cached Biology Technology:Golden Seeds Opens Office in PLSG Incubator 2Golden Seeds Opens Office in PLSG Incubator 3Global High Throughput Screening (HTS) Industry 2Global High Throughput Screening (HTS) Industry 3Global High Throughput Screening (HTS) Industry 4Global High Throughput Screening (HTS) Industry 5Global High Throughput Screening (HTS) Industry 6Global High Throughput Screening (HTS) Industry 7Global High Throughput Screening (HTS) Industry 8Scripps research scientists find clue to cause of childhood hydrocephalus 2Scripps research scientists find clue to cause of childhood hydrocephalus 3Scripps research scientists find clue to cause of childhood hydrocephalus 4
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today ... differences in genetic ancestry of individuals from across ... immigrants first arrived more than four hundred years ago, ... as a meeting place for peoples from different continents. ... mixing of peoples with African, European, and American origins ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) ... in the August issue of Hepatology , a ... Liver Diseases, found that metabolic syndrome significantly increases risk ... to data from the National Cancer Institute, 24,120 new ...
... , This release is available in German ... on the outer membrane for the absorption of viruses like ... well-protected against pathogenic germs. However, certain viruses, such as the ... via the mucous membrane. Just how this infiltration occurs on ...
... natural cycle that dictates our biological processes over a 24-hour ... or wake. Disruptions in the cycle are also associated with ... Prof. Yoav Gothilf of Tel Aviv University,s Department of Neurobiology ... looking to the common zebrafish to learn more about how ...
Cached Biology News:Metabolic syndrome increases risk of both major types of primary liver cancer 2Scavenger cells accomplices to viruses 2Repairing our inner clock with a 2-inch fish 2Repairing our inner clock with a 2-inch fish 3
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... Ion Chromatography requirements, IonQuest will ... The newly developed conductivity detector ... exceptionally ultra-low drift . The ... creates even higher sensitivities for ...
... Bionic Buffer is a unique ... and TAE (TRIS acetate-EDTA) electrophoresis buffers. ... runs, extremely rapid running times, and ... use in gel electrophoresis after dilution ...
Fujifilm Pictro-Color Process for sharp, clear reproduction comparable to silver-halide photography. Photorealistic 400 dpi quality. A4 and A5 output....
Biology Products: